本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Akoya Biosciences, Inc.

0.9999
+0.05425.73%
盘后0.9949-0.0050-0.50%19:14 EDT
成交量:9.97万
成交额:9.72万
市值:4,987.04万
市盈率:-1.04
高:1.00
开:0.9310
低:0.9310
收:0.9457
数据加载中...
2025/02/11

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/01/16

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/01/16

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/01/15

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/01/14

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/01/10

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/01/10

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/01/10

重要事件披露

Form 8-K - Current report
2025/01/10

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/01/10

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2024/12/13

重要事件披露

Form 8-K - Current report
2024/11/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/15

重要事件披露

Form 8-K - Current report
2024/11/04

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/04

重要事件披露

Form 8-K - Current report
2024/08/28

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/08/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/05

重要事件披露

Form 8-K - Current report
2024/06/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities